The 4 analysts offering 12-month price forecasts for Allovir Inc have a median target of 32.00, with a high estimate of 34.00 and a low estimate of 30.00. The median estimate represents a +751.06% increase from the last price of 3.76.
The current consensus among 4 polled investment analysts is to Buy stock in Allovir Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.70
Reporting Date Sep 07
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.